These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 11570204)
1. Persistent localized rash after trauma. Infection or iatrogenic disease? Keith MP; Spooner K Postgrad Med; 2001 Sep; 110(3):37-8. PubMed ID: 11570204 [No Abstract] [Full Text] [Related]
2. Pruritic eruption on the chest. Chwen CC J Fam Pract; 2014 Nov; 63(11):677-9. PubMed ID: 25362492 [TBL] [Abstract][Full Text] [Related]
3. Clobetasol--a potent new topical corticosteroid. Med Lett Drugs Ther; 1986 Jun; 28(715):57-9. PubMed ID: 3520267 [No Abstract] [Full Text] [Related]
4. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants. Cherian MP; AbdulJabbar M Saudi Med J; 2001 Dec; 22(12):1139-41. PubMed ID: 11802195 [No Abstract] [Full Text] [Related]
8. Unregulated use of clobetasol propionate. Keane FM; Munn SE; Taylor NF; du Vivier AW Br J Dermatol; 2001 May; 144(5):1095-6. PubMed ID: 11359411 [No Abstract] [Full Text] [Related]
9. Plasma cell vulvitis and response to topical steroids: a case report. David L; Massey K Int J STD AIDS; 2003 Aug; 14(8):568-9. PubMed ID: 12935388 [TBL] [Abstract][Full Text] [Related]
10. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial. Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513 [TBL] [Abstract][Full Text] [Related]
13. Topical application of clobetasol 17-propionate from various cream bases by using Wistar rat as an animal model. Fang JY; Shen KL; Huang YB; Wu PC; Tsai YH Kaohsiung J Med Sci; 1998 May; 14(5):286-93. PubMed ID: 9619014 [TBL] [Abstract][Full Text] [Related]
14. Bromoderma in a pituitary adenoma patient treated with bromocriptine. Maeda S; Kajihara I; Ogata A; Johno T; Jinnin M; Ihn H J Dermatol; 2017 May; 44(5):e95-e96. PubMed ID: 27859507 [No Abstract] [Full Text] [Related]
15. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094 [TBL] [Abstract][Full Text] [Related]
17. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone. Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704 [TBL] [Abstract][Full Text] [Related]
18. Topical application of clobetasol-17-propionate inhibits the intra-epidermal accumulation of polymorphonuclear leukocytes. Chang A; van de Kerkhof PC Acta Derm Venereol; 1988; 68(1):57-60. PubMed ID: 2449013 [TBL] [Abstract][Full Text] [Related]
19. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis. Decroix J; Pres H; Tsankov N; Poncet M; Arsonnaud S Cutis; 2004 Sep; 74(3):201-6. PubMed ID: 15499763 [TBL] [Abstract][Full Text] [Related]
20. [Benefit of topical steroids in necrotic angiodermatitis]. Carre D; Dompmartin A; Gislard A; Loree S; Faguer K; Verneuil L; Leroy D Ann Dermatol Venereol; 2003 May; 130(5):547-8. PubMed ID: 12843834 [No Abstract] [Full Text] [Related] [Next] [New Search]